SLNO icon

Soleno Therapeutics
SLNO

Overview Fund Activity

33 hedge funds and large institutions have $48.5M invested in Soleno Therapeutics in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+12
Holders Change %
+57.14%
% of All Funds
0.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
8
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VC
1
Vivo Capital
California
$4.81M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.38M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$916K
4
BNP Paribas Financial Markets
4
BNP Paribas Financial Markets
France
$333K
5
Millennium Management
5
Millennium Management
New York
$322K

Top Sellers

1
BC
1
Birchview Capital
Vermont
$480K
2
JGC
2
J. Goldman & Co
New York
$336K
3
SAM
3
Shikiar Asset Management
New York
$0
4
6CM
4
683 Capital Management
New York
$952K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$277K
Name Holding Trade Value Shares
Change 		Shares
Change %
LC
26
Lindbrook Capital
California
$22K -$3.72K -106 -14%
Bank of America
27
Bank of America
North Carolina
$19K +$18.9K +543 +27,150%
UBS Group
28
UBS Group
Switzerland
$13K +$8.61K +233 +196%
MF
29
Manchester Financial
California
$5K +$5K +133 New
CSS
30
Cubist Systematic Strategies
Connecticut
$2K +$2K +42 New
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$1K – – –
Morgan Stanley
32
Morgan Stanley
New York
$1K +$815 +22 +440%
SAM
33
Shikiar Asset Management
New York
– -$104K -2,367 Closed
1
2